Abstract
Genetic testing based on whole-genome sequencing (WGS) often returns results that are not directly clinically actionable as well as raising the possibility of incidental (secondary) findings. In this article, we first survey the laws and policies guiding both researchers and clinicians in the return of results for WGS-based genetic testing. We then provide an overview of the landscape of international legislation and policies for return of these results, including considerations for return of incidental findings. Finally, we consider a range of approaches for the return of results.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Feeding back of individual genetic results in Botswana: mapping opportunities and challenges
BMC Medical Ethics Open Access 03 June 2023
-
Return of research results (RoRR) to the healthy CHRIS cohort: designing a policy with the participants
Journal of Community Genetics Open Access 09 July 2021
-
Whether, when, how, and how much? General public’s and cancer patients’ views about the disclosure of genomic secondary findings
BMC Medical Genomics Open Access 26 June 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hall, A., Finnegan, T. & Alberg, C. Realising genomics in clinical practice. PHG Foundation [online], (2014).
Wade, C. H., Tarini, B. A. & Wilfond, B. S. Growing up in a genomic era: implications of whole-genome sequencing for children, families, and pediatric practice. Annu. Rev. Genomics Hum. Genet. 14, 535–555 (2013).
Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405–423 (2015).
Zawati, M. H. & Knoppers, B. M. International normative perspectives on the return of individual research results and incidental findings in genomic biobanks. Genet. Med. 14, 484–489 (2012).
Parliament of Estonia. Human Genes Research Act. Estonia Legal Text [online], (2000).
Parliament of Spain. Law 14/2007 of 3 July on Biomedical Research. Instituto de Salud Carlos III [online], (2007).
Parliament of Taiwan. Human Biobank Management Act. Laws and regulations database of the republic of China. Laws & Regulations Database of The Republic of China [online], (2010).
Parliament of Finland. Biobank Act 688/2012. Finland Ministry of Social Affairs and Health [online], (2012).
ACMG Board of Directors. ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing. Genet. Med. 17, 68–69 (2015).
Boycott, K. et al. The clinical application of genome-wide sequencing for monogenic diseases in Canada: position statement of the Canadian College of Medical Geneticists. J. Med. Genet. 52, 431–437 (2015).
Knoppers, B. M., Avard, D., Sénécal, K., Zawati, M. H. & P3G International Paediatrics Platform Members. Return of whole-genome sequencing results in paediatric research: a statement of the P3G international paediatrics platform. Eur. J. Hum. Genet. 22, 3–5 (2014).
Ethical Advisory Group of the UK10K Project. Ethical governance framework. UK10K[online], (2010).
Danish Council of Ethics. Genome testing: ethical dilemmas in relation to diagnostics, research and direct-to consumer testing. Danish Council of Ethics [online], (2012).
World Medical Association. WMA declaration of Helsinki — ethical principles for medical research involving human subjects. WMA[online], (2013).
United Nations Educational, Scientific and Cultural Organization. Universal declaration on the human genome and human rights. UNESCO[online], (1997).
Council of Europe. Convention for the protection of human rights and dignity of the human being with regard to the application of biology and medicine: convention on human rights and biomedicine. Council of Europe Treaty Office [online], (1997).
Medical Research Council. Framework on the feedback of health-related findings in research. Wellcome Trust[online], (2014).
Hall, A., Hallowell, N. & Zimmern, R. Managing Incidental and Pertinent Findings from WGS in the 100,000 Genomes Project. PHG Foundation[online], (2013).
Wright, C. et al. Next steps in the sequence: the implications of whole genome sequencing for health. PHG Foundation[online], (2011).
Thorogood, A., Joly, Y. & Knoppers, B. M. An implementation framework for the feedback of individual research results and incidental findings in research. BMC Med. Ethics 15, 1–13 (2014).
Zawati, M. H. & Rioux, A. Biobanks and the return of research results: out with the old and in with the new? J. Law Med. Ethics 39, 614–620 (2011).
Kass, N. E. et al. The research-treatment distinction: a problematic approach for determining which activities should have ethical oversight. Hastings Cent. Rep. 43, S4–S15 (2013).
Thorogood, A. et al. Whole-genome sequencing and the physician. Clin. Genet. 81, 511–513 (2012).
Saunders, C. J. et al. Rapid whole-genome sequencing for genetic disease diagnosis in neonatal intensive care units. Sci. Transl Med. 4, 154a135 (2012).
Weiner, C. Anticipate and communicate. Ethical management of incidental and secondary findings in the clinical, research, and direct-to-consumer contexts (December 2013 report of the Presidential Commission for the Study of Bioethical Issues). Am. J. Epidemiol. 180, 562–564 (2013).
American College of Medical Genetics and Genomics. ACMG updates recommendation on “opt out” for genome sequencing return of results. ACMG News[online], (2014).
German National Ethics Council. The future of genetic diagnosis — from research to clinical practice. Deutscher Ethikrat[online], (Germany, 2013).
Zawati, M. H., Parry, D. & Knoppers, B. M. The best interests of the child and the return of results in genetic research: international comparative perspectives. BMC Med. Ethics 15, 72 (2014).
Whorthey, E. A. Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genet. Med. 13, 255–262 (2011).
Mayer, A. N. et al. A timely arrival for genomic medicine. Genet. Med. 13, 195–196 (2011).
Mendel's Pod. Father/scientist finds gene responsible for daughter's unknown syndrome: Hugh Rienhoff talks personal genomics. Mendel's Pod[online]
Goh, V. et al. Next-generation sequencing facilitates the diagnosis in a child with twinkle mutations causing cholestatic liver failure. J. Pediatr. Gastroenterol. Nutr. 54, 291–294 (2012).
Hawcutt, D. B. et al. Paediatric pharmacogenomics: an overview, Arch. Dis. Child. 98, 232–237 (2013).
Steven, A. et al. Pediatric perspective on pharmacogenomics. Pharmacogenomics. 14, 1889–1905 (2013).
Amor, D. J. Future of whole genome sequencing. J. Paediatr. Child Health. 51, 251–254 (2014).
Green, R. C. et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet. Med. 15, 565–574 (2013).
Botkin, J. R. et al. Points to consider: ethical, legal, and psychological implications of genetic testing in children and adolescents. Am. J. Hum. Genet. 97, 6–21 (2015).
van El, C. G. et al. Whole-genome sequencing in health care. Recommendations of the European Society of Human Genetics. Eur. Soc. Hum. Genet. 21 (Suppl. 1), 1–5 (2013).
Hens, K. et al. Developing a policy for paediatric biobanks: principles for good practice. Eur. J. Hum. Genet. 21, 2–7 (2013).
Knoppers, B. M., Sénécal, K., Borry, P. & Avard, D. Whole genome sequencing in newborn screening programs. Sci. Transl Med. 6, 229cm2 (2014).
Howard, H. C. et al. Whole genome sequencing in newborn screening? A statement on the continued importance of targeted approach in newborn screening programmes. Eur. J. Hum. Genet. http://dx.doi.org/10.1038/ejhg.2014.289 (2015).
Paxton, A. Next-gen shifts DNA sequencing into hyperdrive. CAP Today[online], (2011).
Knoppers, B. M., Deschênes, M., Zawati, M. H. & Tassé, A. M. Population studies: return of research results and incidental findings policy statement. Eur. J. Hum. Genet. 21, 245–247 (2013).
ACMG Board of Directors. Points to consider in the clinical application of genomic sequencing. Genet. Med. 14, 759–761 (2012).
ACMG Board of Directors. Points to consider for informed consent for genome/exome sequencing. Genet. Med. 15, 748–749 (2013).
American College of Medical Genetics and Genomics. Incidental findings in clinical genomics: a clarification. Genet. Med. 15, 664–666 (2013).
Gutmann, A. Privacy and progress in whole genome sequencing. Presidential Commission for the Study of Bioethical Issues [online], (2012).
Acknowledgements
The authors thank E. Kleiderman and A. Pack (from the Centre of Genomics and Policy) for their assistance. In addition, the authors thank the Ministère de l'Économie, l'Innovation et des Exportations du Québec; the Fonds de Recherche du Québec; the Network of Applied Genetic Medicine of Québec; and Care4Rare Canada Consortium funded by Genome Canada, the Canadian Institutes of Health Research, the Ontario Genomics Institute, Ontario Research Fund, Genome Quebec and Children's Hospital of Eastern Ontario Foundation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Knoppers, B., Zawati, M. & Sénécal, K. Return of genetic testing results in the era of whole-genome sequencing. Nat Rev Genet 16, 553–559 (2015). https://doi.org/10.1038/nrg3960
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrg3960
This article is cited by
-
Feeding back of individual genetic results in Botswana: mapping opportunities and challenges
BMC Medical Ethics (2023)
-
The return of individual genomic results to research participants: design and pilot study of Tohoku Medical Megabank Project
Journal of Human Genetics (2022)
-
Whether, when, how, and how much? General public’s and cancer patients’ views about the disclosure of genomic secondary findings
BMC Medical Genomics (2021)
-
A quantitative genomics map of rice provides genetic insights and guides breeding
Nature Genetics (2021)
-
Please give me a copy of my child’s raw genomic data
npj Genomic Medicine (2021)